Asthma Control
Test (ACT)
The same validated 5-question tool used in clinical practice to assess your asthma control over the past 4 weeks.
Answer based on how your asthma has been over the past 4 weeks — this is the same tool used in clinical practice.
| Score | Interpretation | Next Step |
|---|---|---|
| 20-25 | Likely well-controlled | Continue current management, routine follow-up |
| 16-19 | Not well-controlled | Discuss treatment adjustment with your doctor |
| 5-15 | Very poorly controlled | Prompt medical evaluation recommended |
A change of 3+ points between assessments is considered clinically meaningful (minimally important difference).
What Is the Asthma Control Test?
The Asthma Control Test (ACT) is a validated, self-administered 5-question survey developed by Nathan and colleagues in 2004, designed to assess asthma control over the previous 4 weeks. Each question is scored on a 1-5 scale, producing a total score between 5 and 25 — the exact same tool used by pulmonologists and primary care physicians in routine clinical practice, not a simplified or unofficial version. It's specifically designed to be completed by the patient themselves, without requiring a spirometry (lung function) test, making it a genuinely practical tool for regular self-monitoring between doctor visits.
The score interpretation is straightforward: 20-25 suggests asthma is likely well-controlled, 16-19 suggests it's not well-controlled, and 15 or below suggests very poorly controlled asthma warranting prompt medical attention.
How Accurate Is the ACT Compared to Clinical Assessment?
Multiple validation studies have compared ACT scores against the GINA (Global Initiative for Asthma) guideline-based clinical assessment — considered the reference clinical standard. Research found the ACT's area under the curve ranged from 0.84 to 0.92 across different studies (a measure of how well the test distinguishes controlled from uncontrolled asthma, where 1.0 would be perfect), and specifically found that a score of 19 or below correctly identified GINA-defined uncontrolled asthma approximately 94% of the time. This level of agreement is genuinely strong for a 5-question self-report tool, which is exactly why it's become the most widely used control-assessment questionnaire in both clinical practice and research settings.
Why the ACT Doesn't Require Lung Function Testing
🌬️ GINA Assessment
The full GINA clinical assessment includes spirometry (lung function testing, specifically FEV1) alongside symptom questions — comprehensive, but requiring clinical equipment and a healthcare visit.
📝 ACT Assessment
Relies purely on symptom-based questions, making it genuinely practical for frequent self-monitoring at home, work, or anywhere — without needing to visit a clinic for each assessment.
This is exactly why the ACT has such practical value between doctor visits — you can track your own control trend over weeks or months using this tool alone, then bring that trend data to your next appointment as useful context, even though a comprehensive clinical evaluation (including spirometry when appropriate) remains valuable periodically.
Understanding the Minimally Important Difference (MID)
Research has established the minimally important difference (MID) for the ACT at 3 points — meaning a change of 3 or more points between two assessments (whether improvement or decline) represents a genuinely meaningful clinical change, not just normal day-to-day variation in how you happened to answer the questions. This is a practically useful benchmark if you're tracking your ACT score over time, whether after starting a new medication, adjusting an existing treatment, or simply monitoring for seasonal changes in control — a 1-2 point fluctuation between assessments is within expected noise, while a 3+ point shift suggests something has genuinely changed.
Why Regular Reassessment Matters
Asthma control genuinely fluctuates over time — due to seasonal allergen exposure, respiratory infections, medication adherence changes, or evolving disease severity — which is exactly why the ACT asks about the past 4 weeks specifically, rather than "ever" or "right now." Retaking the ACT periodically (many patients complete it at each doctor visit, or monthly if self-monitoring) provides a trend over time that's genuinely more clinically useful than any single assessment in isolation, helping both you and your doctor identify whether current management is working or needs adjustment.
A Separate Version Exists for Children
It's worth knowing that the standard ACT described on this page is validated specifically for ages 12 and older. A separate, age-appropriate version — the Childhood Asthma Control Test (C-ACT) — exists for younger children (ages 4-11), using simpler language and incorporating both a parent-reported and child-reported component, since younger children often can't reliably self-report symptom frequency and severity the way adolescents and adults can. Research comparing both versions against GINA clinical criteria found the standard ACT (validated for 12+) showed notably stronger predictive accuracy than the C-ACT in identifying uncontrolled asthma, which is part of why age-appropriate tool selection genuinely matters rather than simply using a downward-adjusted version of the adult tool for younger children.
How UK Guidance Compares
UK asthma management guidance, from NICE and the British Thoracic Society, doesn't specifically mandate the ACT as its primary control-assessment tool, instead commonly referencing the related Asthma Control Questionnaire (ACQ) or symptom-based criteria drawn from GINA guidelines, which the ACT itself was validated against. Both the ACT and ACQ are internationally recognized, validated tools measuring essentially the same underlying construct (asthma control) through slightly different specific questions and scoring systems — research comparing the two found generally strong agreement between them, meaning the choice between ACT and ACQ in a given healthcare system often reflects institutional preference and historical adoption patterns as much as any meaningful clinical difference. If your UK clinician uses the ACQ specifically rather than the ACT, that's a genuinely valid, equally evidence-based alternative measuring the same core concept.
Related Health Context
Respiratory health connects to broader environmental and lifestyle factors. If air quality or allergen exposure is relevant to your asthma triggers, tracking symptom patterns alongside seasonal changes can add useful context to your ACT trend. Our Noise Exposure Calculator covers another environmental health monitoring tool that follows a similar self-tracking principle.
